Atai Life Sciences N.V. logo

Atai Life Sciences N.V.

NASDAQ:ATAI

Overview | Financials
Company Name Atai Life Sciences N.V.
Symbol ATAI
Currency USD
Price 1.28
Market Cap 214,786,560
Dividend Yield 0%
52-week-range 1.03 - 2.85
Industry Biotechnology
Sector Healthcare
CEO Mr. Florian Brand
Website https://www.atai.life

An error occurred while fetching data.

About Atai Life Sciences N.V.

Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007,

Related Stocks

Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc.

AVIR

3.33 USD

InnovAge Holding Corp. logo

InnovAge Holding Corp.

INNV

3.92 USD

Aurora Cannabis Inc. logo

Aurora Cannabis Inc.

ACB

4.3 USD

HealthStream, Inc. logo

HealthStream, Inc.

HSTM

31.75 USD

iTeos Therapeutics, Inc. logo

iTeos Therapeutics, Inc.

ITOS

7.32 USD

ZimVie Inc. logo

ZimVie Inc.

ZIMV

14.04 USD

Avidity Biosciences, Inc. logo

Avidity Biosciences, Inc.

RNA

30.11 USD

Nkarta, Inc. logo

Nkarta, Inc.

NKTX

2.41 USD

Financials

Numbers are in millions USD

Numbers are in millions USD